<?xml version="1.0" encoding="UTF-8"?>
<ref id="bph15207-bib-0049">
 <mixed-citation publication-type="journal" id="bph15207-cit-0050">
  <string-name>
   <surname>Kollias</surname>, 
   <given-names>A.</given-names>
  </string-name>, 
  <string-name>
   <surname>Kyriakoulis</surname>, 
   <given-names>K. G.</given-names>
  </string-name>, 
  <string-name>
   <surname>Dimakakos</surname>, 
   <given-names>E.</given-names>
  </string-name>, 
  <string-name>
   <surname>Poulakou</surname>, 
   <given-names>G.</given-names>
  </string-name>, 
  <string-name>
   <surname>Stergiou</surname>, 
   <given-names>G. S.</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>Syrigos</surname>, 
   <given-names>K.</given-names>
  </string-name> (
  <year>2020</year>). 
  <article-title>Thromboembolic risk and anticoagulant therapy in COVID‐19 patients: Emerging evidence and call for action</article-title>. 
  <source xml:lang="en">British Journal of Haematology</source>, 
  <volume>189</volume>(
  <issue>5</issue>), 
  <fpage>846</fpage>–
  <lpage>847</lpage>. 
  <pub-id pub-id-type="doi">10.1111/bjh.16727</pub-id>
  <pub-id pub-id-type="pmid">32304577</pub-id>
 </mixed-citation>
</ref>
